ERNA vs JAZZ · P/E 0.0, rev $582.0K vs P/E 1988, rev $4.07B
Eterna Therapeutics Inc (ERNA) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the ERNA and JAZZ stock pages for the full models.
Not investment advice.